Cargando…
Expression of Glycogen Phosphorylase Isoforms in Cultured Muscle from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation
BACKGROUND: Mutations in the PYGM gene encoding skeletal muscle glycogen phosphorylase (GP) cause a metabolic disorder known as McArdle's disease. Previous studies in muscle biopsies and cultured muscle cells from McArdle patients have shown that PYGM mutations abolish GP activity in skeletal m...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950139/ https://www.ncbi.nlm.nih.gov/pubmed/20957198 http://dx.doi.org/10.1371/journal.pone.0013164 |
_version_ | 1782187628906414080 |
---|---|
author | Nogales-Gadea, Gisela Mormeneo, Emma García-Consuegra, Inés Rubio, Juan C. Orozco, Anna Arenas, Joaquin Martín, Miguel A. Lucia, Alejandro Gómez-Foix, Anna M. Martí, Ramon Andreu, Antoni L. |
author_facet | Nogales-Gadea, Gisela Mormeneo, Emma García-Consuegra, Inés Rubio, Juan C. Orozco, Anna Arenas, Joaquin Martín, Miguel A. Lucia, Alejandro Gómez-Foix, Anna M. Martí, Ramon Andreu, Antoni L. |
author_sort | Nogales-Gadea, Gisela |
collection | PubMed |
description | BACKGROUND: Mutations in the PYGM gene encoding skeletal muscle glycogen phosphorylase (GP) cause a metabolic disorder known as McArdle's disease. Previous studies in muscle biopsies and cultured muscle cells from McArdle patients have shown that PYGM mutations abolish GP activity in skeletal muscle, but that the enzyme activity reappears when muscle cells are in culture. The identification of the GP isoenzyme that accounts for this activity remains controversial. METHODOLOGY/PRINCIPAL FINDINGS: In this study we present two related patients harbouring a novel PYGM mutation, p.R771PfsX33. In the patients' skeletal muscle biopsies, PYGM mRNA levels were ∼60% lower than those observed in two matched healthy controls; biochemical analysis of a patient muscle biopsy resulted in undetectable GP protein and GP activity. A strong reduction of the PYGM mRNA was observed in cultured muscle cells from patients and controls, as compared to the levels observed in muscle tissue. In cultured cells, PYGM mRNA levels were negligible regardless of the differentiation stage. After a 12 day period of differentiation similar expression of the brain and liver isoforms were observed at the mRNA level in cells from patients and controls. Total GP activity (measured with AMP) was not different either; however, the active GP activity and immunoreactive GP protein levels were lower in patients' cell cultures. GP immunoreactivity was mainly due to brain and liver GP but muscle GP seemed to be responsible for the differences. CONCLUSIONS/SIGNIFICANCE: These results indicate that in both patients' and controls' cell cultures, unlike in skeletal muscle tissue, most of the protein and GP activities result from the expression of brain GP and liver GP genes, although there is still some activity resulting from the expression of the muscle GP gene. More research is necessary to clarify the differential mechanisms of metabolic adaptations that McArdle cultures undergo in vitro. |
format | Text |
id | pubmed-2950139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-29501392010-10-18 Expression of Glycogen Phosphorylase Isoforms in Cultured Muscle from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation Nogales-Gadea, Gisela Mormeneo, Emma García-Consuegra, Inés Rubio, Juan C. Orozco, Anna Arenas, Joaquin Martín, Miguel A. Lucia, Alejandro Gómez-Foix, Anna M. Martí, Ramon Andreu, Antoni L. PLoS One Research Article BACKGROUND: Mutations in the PYGM gene encoding skeletal muscle glycogen phosphorylase (GP) cause a metabolic disorder known as McArdle's disease. Previous studies in muscle biopsies and cultured muscle cells from McArdle patients have shown that PYGM mutations abolish GP activity in skeletal muscle, but that the enzyme activity reappears when muscle cells are in culture. The identification of the GP isoenzyme that accounts for this activity remains controversial. METHODOLOGY/PRINCIPAL FINDINGS: In this study we present two related patients harbouring a novel PYGM mutation, p.R771PfsX33. In the patients' skeletal muscle biopsies, PYGM mRNA levels were ∼60% lower than those observed in two matched healthy controls; biochemical analysis of a patient muscle biopsy resulted in undetectable GP protein and GP activity. A strong reduction of the PYGM mRNA was observed in cultured muscle cells from patients and controls, as compared to the levels observed in muscle tissue. In cultured cells, PYGM mRNA levels were negligible regardless of the differentiation stage. After a 12 day period of differentiation similar expression of the brain and liver isoforms were observed at the mRNA level in cells from patients and controls. Total GP activity (measured with AMP) was not different either; however, the active GP activity and immunoreactive GP protein levels were lower in patients' cell cultures. GP immunoreactivity was mainly due to brain and liver GP but muscle GP seemed to be responsible for the differences. CONCLUSIONS/SIGNIFICANCE: These results indicate that in both patients' and controls' cell cultures, unlike in skeletal muscle tissue, most of the protein and GP activities result from the expression of brain GP and liver GP genes, although there is still some activity resulting from the expression of the muscle GP gene. More research is necessary to clarify the differential mechanisms of metabolic adaptations that McArdle cultures undergo in vitro. Public Library of Science 2010-10-05 /pmc/articles/PMC2950139/ /pubmed/20957198 http://dx.doi.org/10.1371/journal.pone.0013164 Text en Nogales-Gadea et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Nogales-Gadea, Gisela Mormeneo, Emma García-Consuegra, Inés Rubio, Juan C. Orozco, Anna Arenas, Joaquin Martín, Miguel A. Lucia, Alejandro Gómez-Foix, Anna M. Martí, Ramon Andreu, Antoni L. Expression of Glycogen Phosphorylase Isoforms in Cultured Muscle from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation |
title | Expression of Glycogen Phosphorylase Isoforms in Cultured Muscle from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation |
title_full | Expression of Glycogen Phosphorylase Isoforms in Cultured Muscle from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation |
title_fullStr | Expression of Glycogen Phosphorylase Isoforms in Cultured Muscle from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation |
title_full_unstemmed | Expression of Glycogen Phosphorylase Isoforms in Cultured Muscle from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation |
title_short | Expression of Glycogen Phosphorylase Isoforms in Cultured Muscle from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation |
title_sort | expression of glycogen phosphorylase isoforms in cultured muscle from patients with mcardle's disease carrying the p.r771pfsx33 pygm mutation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950139/ https://www.ncbi.nlm.nih.gov/pubmed/20957198 http://dx.doi.org/10.1371/journal.pone.0013164 |
work_keys_str_mv | AT nogalesgadeagisela expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation AT mormeneoemma expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation AT garciaconsuegraines expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation AT rubiojuanc expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation AT orozcoanna expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation AT arenasjoaquin expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation AT martinmiguela expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation AT luciaalejandro expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation AT gomezfoixannam expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation AT martiramon expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation AT andreuantonil expressionofglycogenphosphorylaseisoformsinculturedmusclefrompatientswithmcardlesdiseasecarryingthepr771pfsx33pygmmutation |